Нишондиҳанда
Маълумоти фаврӣ:
4мг, 8мг
7 мл флакони қубурӣ бо филп-хомӯш, 1's/box, 10's/box, 50s/box
Дастгирии OEM/ODM:ҳа
MOQ:10000 Қуттиҳо
Вақти расондан:30 ~ 55 рӯз
Мӯҳлати савдои:ФОБ, CIF
Мўњлати пардохти:Т / T, L / C
Стандарт дастрас:CP, BP
Ҳуҷҷатҳои:GMP, CPP, FSC, CTD
Нишондиҳандаҳо
Nicergoline for injection, indications are
1. Improvement of hypochondriacal and affective disorders (dullness of sensation, inattention, memory loss, lack of intention, depression, restlessness, etc.) caused by the sequelae of cerebral infarction.
2. Acute and chronic peripheral circulation disorders (vaso-occlusive diseases of the limbs, Raynaud's syndrome, other symptoms of poor peripheral circulation).
Натиҷаҳои номатлуб
No serious adverse reactions have been reported. Hypotension, dizziness, stomach pain, hot flushes, facial flushing, drowsiness and insomnia may be observed. Elevated uric acid concentrations in the blood may be observed in clinical trials, but this phenomenon does not correlate with the amount and duration of administration.
Зеркашӣ
Дар ҷои хунук, хушк ва торик нигоҳ доред.
Ҳама доруҳоро аз кӯдакон дур нигоҳ доред.